Last reviewed: June 10, 2026
Last updated: June 10, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
When patients lose significant weight using semaglutide or other GLP-1 medications, skin appearance often changes—sometimes improving, sometimes revealing new concerns like cellulite. Research shows that approximately 85% of women experience some degree of cellulite regardless of weight, and while GLP-1 therapy can reduce the fat deposits underneath skin, cellulite management requires a multi-faceted approach that extends beyond medication alone.
How GLP-1 Medications Affect Skin During Weight Loss
GLP-1 receptor agonists like semaglutide work by slowing gastric emptying and increasing satiety, leading to consistent caloric deficit and gradual fat loss. When subcutaneous fat decreases, the skin overlying that fat may tighten or appear smoother in some areas—particularly where fat loss is most pronounced. However, the appearance of cellulite depends on multiple factors beyond fat volume, including collagen density, skin elasticity, inflammation levels, and individual genetic predisposition.
Clinical trials tracking body composition changes show that patients on semaglutide lose approximately 15-22% of body weight over 68 weeks, with the majority of loss coming from adipose tissue. This significant reduction can make existing cellulite less visually prominent because the overall tissue beneath the skin becomes smaller and firmer. That said, cellulite dimpling is fundamentally a structural issue related to how fibrous connective tissue anchors to underlying fascia, not simply a fat volume problem.
Why Cellulite Persists Even With Weight Loss From Semaglutide
Cellulite forms when fat compartments push upward through weakened or inflexible connective tissue septae, creating the characteristic dimpled or cottage-cheese appearance. Studies indicate that collagen fiber arrangement, not fat thickness alone, determines cellulite severity—which is why extremely lean individuals can still have visible cellulite. When patients lose weight rapidly via GLP-1 therapy without simultaneously strengthening connective tissue elasticity, the skin may appear looser or show cellulite more clearly because the skin envelope hasn't had time to contract proportionally.
Hormonal factors, inflammation markers, and microcirculation efficiency also influence cellulite visibility. Semaglutide reduces systemic inflammation and improves metabolic markers, which can theoretically support better skin health, but these effects work slowly over months. Additionally, patients who experience rapid weight loss sometimes develop loose or sagging skin if weight loss outpaces collagen remodeling—a process that requires adequate protein intake, micronutrient status, and time.
Genetic Predisposition to Cellulite and Metabolic Response
PlexusDx's Precision Peptide Genetic Test identifies variants in genes like FTO rs9939609 and MC4R rs17782313 that influence fat distribution patterns and metabolic efficiency. Patients with certain genetic profiles may store subcutaneous fat in patterns that make cellulite more or less visible, and they may also respond differently to GLP-1 therapy in terms of where fat loss occurs first. Understanding your genetic predisposition to cellulite and adipose tissue distribution can help set realistic expectations about skin appearance changes during weight loss treatment.
The test maps 14 metabolic and appetite-regulation pathways across 49 peptides, providing insights into how your body processes nutrients and distributes fat stores. This information allows patients and clinicians to anticipate which areas of the body may show the most dramatic changes during semaglutide therapy, and to plan complementary strategies for skin health accordingly. Genetic testing at PlexusDx costs $99 as an add-on after the first month of treatment.
Proven Strategies to Manage Cellulite Alongside GLP-1 Treatment
While semaglutide addresses fat reduction, cellulite improvement requires targeted interventions: progressive resistance training, adequate hydration, protein intake of 0.8-1.0g per pound of goal body weight, and dry brushing or massage to improve lymphatic drainage. Resistance exercise, in particular, strengthens underlying muscles and improves dermal blood flow, which can reduce the visual severity of cellulite by up to 25-30% over 12-16 weeks when combined with weight loss. Collagen-supporting micronutrients—vitamin C, copper, and silica—may also support skin elasticity during the remodeling phase.
Topical treatments such as caffeine-based creams and retinoids show modest evidence for temporary cellulite reduction by improving skin hydration and microcirculation at the epidermal level. More invasive options like radiofrequency treatments, laser therapy, or microneedling can stimulate collagen remodeling in areas of persistent cellulite, though results are incremental and require ongoing maintenance. The most effective approach combines GLP-1 therapy for fat loss, strength training for muscle tone, and skin-specific interventions for collagen support—all working synergistically over 6-12 months.
What to Expect for Skin Quality on Semaglutide Injection
Patients beginning compounded semaglutide injection therapy at PlexusDx typically notice initial skin changes within 8-12 weeks as fat loss begins and inflammation markers decrease. Many report that skin tone improves, pores appear smaller, and previously oily areas become more balanced—effects driven by reduced caloric intake and improved metabolic health. Cellulite appearance often stabilizes or moderately improves by month 4-6, though the degree of improvement depends heavily on individual genetics, age, skin elasticity, and adherence to complementary strategies like resistance training and hydration.
PlexusDx provides compounded semaglutide injection from licensed 503A compounding pharmacies starting at $149 per month across all commitment tiers, with no flat per-compound pricing increases—your dose may need to go up, but your price won't. HSA and FSA funds are accepted, no insurance is required, and PlexusDx serves all 50 states. This accessibility allows patients to sustain treatment long-term while implementing lifestyle strategies that maximize both fat loss and skin health outcomes.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Does Ozempic directly treat cellulite, or does it only help through weight loss?
Semaglutide and other GLP-1 medications do not directly target cellulite—they work by reducing overall body fat and improving metabolic health, which can make cellulite less visually prominent. Cellulite improvement during GLP-1 therapy depends on concurrent resistance training, collagen support, and skin-specific interventions, not the medication alone.
Can rapid weight loss from semaglutide actually make cellulite look worse temporarily?
Yes. If weight loss outpaces skin elasticity adaptation, the skin may appear looser initially, making cellulite more visible. This effect typically resolves within 6-12 months as collagen remodeling occurs and muscles strengthen. Consistent resistance training and adequate protein intake (0.8-1.0g per pound of goal weight) can accelerate this process.
How does PlexusDx's genetic testing help predict cellulite risk during weight loss?
PlexusDx's Precision Peptide Genetic Test identifies variants in genes like FTO rs9939609 and MC4R rs17782313 that influence fat distribution patterns. Understanding your genetic profile helps predict where fat loss will be most pronounced and how your skin may respond, allowing you to plan targeted interventions in advance.
What lifestyle changes most effectively reduce cellulite alongside semaglutide therapy?
Progressive resistance training 3-4 times weekly, hydration of 3-4 liters daily, protein intake of 0.8-1.0g per pound of goal body weight, and dry brushing or massage show the strongest evidence. These strategies work synergistically with semaglutide to maximize fat loss, improve skin elasticity, and reduce cellulite appearance over 6-12 months.
Is compounded semaglutide from PlexusDx effective for cellulite improvement like brand-name Ozempic?
Compounded semaglutide from licensed 503A compounding pharmacies (including PlexusDx's sources) contains the same active ingredient as brand-name Ozempic and produces equivalent weight loss outcomes. Cellulite improvement depends on the medication's effect on fat loss and metabolic health, not the source—PlexusDx semaglutide injection starts at $149/month with no flat per-compound pricing increases.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How to Get GLP-1 Naturally for Better Health and Weight Management
Does Ozempic Cause Gas? What You Need to Know About This Common Side Effect